Tauranga boy Riaan Hamilton has cystic fibrosis – the 3-year-old often gets sick, has been hospitalised several times, and is ...

Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex ...

Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.

OXB announces that its proprietary lentiviral vector manufacturing technology will be used in Boehringer Ingelheim’s newly initiated LENTICLAIR ...

About the Cystic Fibrosis Trust Cystic Fibrosis Trust is the only UK-wide charity dedicated to uniting for a life unlimited for everyone affected by cystic fibrosis. The Trust funds cutting edge ...

Tauranga boy Riaan Hamilton has cystic fibrosis. His mother Khali Hamilton hopes Trikafta will be funded after Pharmac's Respiratory Advisory Committee recommended funding Trikafta with high priority ...

Vertex Pharmaceuticals dominates the market for cystic fibrosis drugs ... opinion leaders has indicated the desire for more treatment options for CF patients, support for a new mechanism of ...

From life-altering genetic conditions to promising new treatments, here's what you need to know about 7 inherited diseases ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...

The result is going to be less science, fewer breakthrough therapies, and less innovations,” said Dean Madden of Dartmouth ...

As someone who does not benefit from any CFTR modulators, I only have one option for improving my lung function — transplant. But just because it’s my only choice does not mean it’s an easy one to ...